For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210407:nBwc481wfa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC Amendment
Ap19
FORM 8.3
Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 01 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,748,938 1.36% 190,301 0.15%
(2) Derivatives (other than options):
102,359 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,857,397 1.44% 203,467 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 234.0300 USD
Purchase 7 233.4000 USD
Purchase 8 233.2350 USD
Purchase 40 231.0400 USD
Purchase 95 233.2500 USD
Purchase 100 230.8900 USD
Purchase 100 233.9600 USD
Purchase 110 233.8314 USD
Purchase 117 233.4180 USD
Purchase 136 233.5913 USD
Purchase 140 234.0928 USD
Purchase 149 230.9526 USD
Purchase 220 232.2895 USD
Purchase 281 233.2165 USD
Purchase 323 228.7325 USD
Purchase 994 233.5168 USD
Purchase 1,000 233.5741 USD
Purchase 1,102 233.3006 USD
Purchase 1,951 233.4707 USD
Purchase 2,578 231.6473 USD
Purchase 3,094 232.4596 USD
Purchase 3,395 232.9444 USD
Purchase 4,748 232.9691 USD
Purchase 4,851 233.4254 USD
Purchase 4,926 233.0058 USD
Purchase 5,344 233.5900 USD
Purchase 12,411 232.7435 USD
Purchase 25,600 233.6600 USD
Sale 2 233.9100 USD
Sale 2 233.7100 USD
Sale 8 233.9400 USD
Sale 15 233.3120 USD
Sale 38 233.5950 USD
Sale 40 231.0400 USD
Sale 92 232.9400 USD
Sale 100 230.8900 USD
Sale 100 230.3600 USD
Sale 149 230.9526 USD
Sale 200 233.4450 USD
Sale 206 233.6292 USD
Sale 274 233.0725 USD
Sale 323 228.7325 USD
Sale 500 232.8610 USD
Sale 500 233.3740 USD
Sale 615 232.8644 USD
Sale 800 233.6064 USD
Sale 1,115 233.3674 USD
Sale 1,156 232.9751 USD
Sale 1,736 232.8840 USD
Sale 2,158 232.1661 USD
Sale 3,152 233.0658 USD
Sale 3,394 232.9443 USD
Sale 4,720 232.9786 USD
Sale 5,442 233.5900 USD
Sale 11,783 232.4167 USD
Sale 16,001 233.5232 USD
Sale 19,200 233.6600 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 7 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210407005829/en/
(https://www.businesswire.com/news/home/20210407005829/en/)
BARCLAYS PLC
Copyright Business Wire 2021